2E-3-F16

• UNSPSC Description:

  2E-3-F16 is a anticancer agent. 2E-3-F16 exhibits tumor cell selectivity between NCI-H446 cancer cells and HBE cells. 2E-3-F16 enhances the sensitivity of A549 cells to Cisplatin (HY-17394)[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/2e-3-f16.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C=CCC1=CC(C2=CC=C(C(CC=C)=C2)OCCC[N+]3=CC=C(C=C3)/C=C/C4=CNC5=C4C=CC=C5)=C(C=C1)OCCC.[Br-]

• Molecular Weight:

  649.66

• References & Citations:

  [1]Miao H, et al. Mitochondrial targeting derivatives of honokiol enhanced selective antitumor activity in NCI-H446 cells and decreased in vivo toxicity in Caenorhabditis elegans. Eur J Med Chem. 2023 Dec 3;264:115996.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  3002962-69-5